Key result
Higher baseline miRNA 122-5p is linked to ~12% higher risk of death and CV events in hemodialysis.
Cohort (n=74)
Yes
Answers are grounded in this paper and cite their sources.
Background: Despite patients undergoing chronic hemodialysis (HD) being notoriously prone to adverse cardiovascular (CV) events, risk prediction in this population remains challenging. miRNA 122-5p, a short, non-coding RNA predominantly involved in lipid and carbohydrate metabolism, has recently been related to the onset and progression of CV disease. Methods: We run a pilot, multicenter, longitudinal, observational study to evaluate the clinical significance and prognostic usefulness of circulating miRNA 122-5p in a multicentric cohort of 74 individuals on maintenance HD. Results: Patients displayed lower circulating miRNA 122-5p as compared to healthy controls (p = 0.004). At correlation analyses, ALT (β = 0.333; p = 0.02), E/e’ (β = 0.265; p = 0.02) and CRP (β = −0.219; p = 0.041) were independent predictors of miRNA 122-5p levels. During a median follow-up of 22 months (range of 1–24), 30 subjects (40.5%) experienced a composite endpoint of all-cause mortality and fatal/non-fatal CV events. Baseline circulating miRNA 122-5p was higher in these subjects (p = 0.01) and it predicted a significantly higher risk of endpoint occurrence (Kaplan–Meier crude HR 3.192; 95% CI 1.529–6.663; p = 0.002; Cox regression adjusted HR 1.115; 95% CI 1.009–1.232; p = 0.03). Conclusions: Altered miRNA 122-5p levels in HD patients may reflect hepatic and CV damage and may impart important prognostic information for improving CV risk prediction in this particular setting.
No takes yet. Share an insight, caveat, or question.
Duni et al. (2023) conducted a cohort in Chronic hemodialysis (n=74). Circulating miRNA 122-5p expression vs. Healthy controls / lower circulating miRNA 122-5p levels was evaluated on Composite of all-cause mortality and fatal/non-fatal cardiovascular events (HR 1.115, 95% CI 1.009-1.232, p=0.03). Higher baseline circulating miRNA 122-5p predicted a higher risk of all-cause mortality and CV events in chronic hemodialysis patients.
Synapse has enriched 10 related papers. Consider them for comparative context: